Oscar Segurado, Chief Medical Officer at ASC Therapeutics

Oscar Segurado is an executive veteran of the biopharmaceutical industry with extensive global leadership experience in translational science, clinical development, and medical affairs. Oscar is Chief Medical Officer for ASC Therapeutics, former CMO for Symvivo, Myriad Genetics, and CellMax Life, Vice President for Becton Dickinson, and Global Medical Head for Abbott/AbbVie.Segurado is a senior medical leader experienced in matrixed, line management, and consulting for biotechs, midsize, and large pharma companies. Extensive expertise in gene therapy, immuno-oncology, immunotherapy, genomics, and protein/cell diagnostics, predominantly focused on oncology, hematology, and autoimmunity, including personalized medicine, molecular and cellular biomarkers. He holds a tenured Professorship of Immunology at the University of Leon, Spain, and received Ph.D. from the University of Wuerzburg, Germany, and MD from the University of Salamanca, Spain.